Back to search

Article

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants

2021-09-14

Abstract excerpt

BNT162b2-elicited human sera are known to neutralize the currently dominant Delta SARS-CoV-2 variant. Here, we report the ability of 20 human sera, drawn 2 or 4 weeks after two doses of BNT162b2, to neutralize USA-WA1/2020 SARS-CoV-2 bearing variant spikes from Delta plus (Delta-AY.1, Delta-AY.2), Delta-Δ144 (Delta with the Y144 deletion of the Alpha variant), Lambda, and B. 1.1.519 lineage viruses. Geometric mean...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a68de9d4-eebf-5b3b-abcb-3311bd4bc16a
DOI
10.1101/2021.09.13.460163
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsDOI 10.1101/2021.09.13.460163
Select a neighboring publication to make it the new centre.